{"contentid": 488250, "importid": NaN, "name": "Astellas terminates distribution deal with Toa Eiyo", "introduction": "Japan\u00e2\u0080\u0099s Astellas Pharma and Toa Eiyo have agreed to terminate their distribution agreement on March 31, 2022.", "content": "<p>Japan&rsquo;s Astellas Pharma (TYO: 4503) and Toa Eiyo have agreed to terminate their distribution agreement on March 31, 2022.</p>\n<p>In accordance with this agreement, after April 1, 2022, Toa Eiyo will independently sell and provide information on all 18 products such as Bisono (bisoprolol) tape, a transdermal patch of <em>&beta;</em><sub>1</sub> blocker, for treatment of hypertension and atrial fibrillation and Frandol (isosorbide dinitrate) tablets and tape for treatment of ischemic heart disease, for which Toa Eiyo obtained Marketing Authorization in Japan, that are currently sold on consignment by Astellas.</p>\n<p>Astellas and Toa Eiyo have collaborated for sales and marketing for a long time. Astellas currently sells most of the products and Toa Eiyo provides product information to medical institutions. Both companies have discussed and agreed to terminate the distribution agreement on March 31, 2022.</p>\n<p>Astellas is continuously working on optimizing the allocation of management resources in order to maximize the value of each product, and the termination of the distribution agreement is part of this effort. As a specialty pharmaceutical company in the field of cardiovascular medicine, Toa Eiyo has decided that it is necessary to establish its own sales structure of products in order to meet the diverse needs of cardiovascular treatment.</p>\n<p>Astellas and Toa Eiyo will work closely during the sales transfer process to ensure stable supply of the relevant products and a smooth continuation of activities, including the provision/collection of product information and the promotion of their proper use.</p>", "date": "2021-04-06 10:22:00", "meta_title": "Astellas terminates distribution deal with Toa Eiyo", "meta_keywords": "Astellas,Toa Eiyo, Distribution, Agreement, Terminated, Bisono, Fandol", "meta_description": "Astellas terminates distribution deal with Toa Eiyo", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 3, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-04-05 11:29:01", "updated": "2021-04-06 10:22:37", "access": NaN, "url": "https://www.thepharmaletter.com/article/astellas-terminates-distribution-deal-with-toa-eiyo", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "astellas-logo-big.jpg", "image2id": "astellas-logo-small.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Pharmaceutical", "therapy area_tag": "Cardio-vascular", "topic_tag": "Asia Pacific, Deals, Focus On", "geography_tag": "Japan", "company_tag": "Astellas, Toa Eiyo", "drug_tag": "Bisono, Frandol", "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-04-06 10:22:00"}